Donatella Tondi

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Pharmaceuticals (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

ChemMedChem

ACS infectious diseases

Università degli Studi di Modena e Reggio Emilia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Modena e Reggio Emilia Feb 01 2001

Italy

Ricercatore a tempo indeterminato CHIM08 :: Dipartimento di Scienze della Vita

Publications

Matteo Bersani, Mariacristina Failla, Filippo Vascon, Eleonora Gianquinto, Laura Bertarini, Massimo Baroni, Gabriele Cruciani, Federica Verdirosa, Filomena Sannio, Jean Denis Docquier, Laura Cendron, Francesca Spyrakis, Loretta Lazzarato, Donatella Tondi
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Matteo Bersani, Mariacristina Failla, Filippo Vascon, Eleonora Gianquinto, Laura Bertarini, Massimo Baroni, Gabriele Cruciani, Federica Verdirosa, Filomena Sannio, Jean Denis Docquier, Laura Cendron, Francesca Spyrakis, Loretta Lazzarato, Donatella Tondi
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Lorenza Fagnani, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca, Roberto Iorio, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Donatella Tondi
Novel Targets and Mechanisms in Antimicrobial Drug Discovery. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Eleonora Gianquinto, Donatella Tondi, Giulia D'Arrigo, Loretta Lazzarato, Francesca Spyrakis
Can We Exploit β-Lactamases Intrinsic Dynamics for Designing More Effective Inhibitors? Antibiotics (Basel, Switzerland) 9 (11) (2020)
Francesca Spyrakis, Pierangelo Bellio, Antonio Quotadamo, Pasquale Linciano, Paolo Benedetti, Giulia D'Arrigo, Massimo Baroni, Laura Cendron, Giuseppe Celenza, Donatella Tondi
First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase. Journal of computer-aided molecular design 33 (2) (2019)
Pasquale Linciano, Laura Cendron, Eleonora Gianquinto, Francesca Spyrakis, Donatella Tondi
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design. ACS infectious diseases 5 (1) (2018)
Puneet Saxena, Leda Severi, Matteo Santucci, Laura Taddia, Stefania Ferrari, Rosaria Luciani, Gaetano Marverti, Chiara Marraccini, Donatella Tondi, Marco Mor, Laura Scalvini, Simone Vitiello, Lorena Losi, Sergio Fonda, Salvatore Pacifico, Remo Guerrini, Domenico D'Arca, Glauco Ponterini, Maria Paola Costi
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth. Journal of medicinal chemistry 61 (16) (2018)
Giuseppe Celenza, Mattia Vicario, Pierangelo Bellio, Pasquale Linciano, Mariagrazia Perilli, Antonio Oliver, Jesús Blazquez, Laura Cendron, Donatella Tondi
Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. ChemMedChem 13 (7) (2018)

Donatella Tondi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Donatella Tondi